Add to ORKGNanotechnology could provide a new complementary approach to treat coronary artery disease (CAD) which is now one of the biggest killers in the Western world. The course of events, which leads to atherosclerosis and CAD, involves many biological factors and cellular disease processes which may be mitigated by therapeutic methods enhanced by nanotechnology. Nanoparticles can provide a variety of delivery systems for cargoes such as drugs and genes that can address many problems within the arteries. In order to improve the performance of current stents, nanotechnology provides different nanomaterial coatings, in addition to controlled-release nanocarriers, to prevent in-stent restenosis. Nanotechnology can increase the efficiency of drugs, im...
Coronary artery disease (CAD) is currently a leading cause of death worldwide. In the history of per...
Coronary artery disease (CAD) is one of the most common causes of death worldwide. In the last decad...
Tao Li,* Weitao Liang,* Xijun Xiao, Yongjun Qian Department of Cardiovascular Surgery, West China H...
Nanomedicine is one of the most promising therapeutic modalities researchers are working on. It invo...
Nanotechnology is at the forefront of medical technology. It has a vast number of applications in th...
Nanotechnology is at the forefront of medical technology. It has a vast number of applications in th...
[[abstract]]Nanotechnology can be defined as the science and engineering involved in the design, syn...
[[abstract]]Nanotechnology can be defined as the science and engineering involved in the design, syn...
Cardiovascular diseases are the leading cause of mortality in the Western world. Among them, atheros...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries,...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries,...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries,...
Coronary artery disease (CAD) is one of the most common causes of death worldwide. In the last decad...
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality worldwide. However,...
Cardiovascular diseases (CVDs) represent the most important epidemic of our century, with more than ...
Coronary artery disease (CAD) is currently a leading cause of death worldwide. In the history of per...
Coronary artery disease (CAD) is one of the most common causes of death worldwide. In the last decad...
Tao Li,* Weitao Liang,* Xijun Xiao, Yongjun Qian Department of Cardiovascular Surgery, West China H...
Nanomedicine is one of the most promising therapeutic modalities researchers are working on. It invo...
Nanotechnology is at the forefront of medical technology. It has a vast number of applications in th...
Nanotechnology is at the forefront of medical technology. It has a vast number of applications in th...
[[abstract]]Nanotechnology can be defined as the science and engineering involved in the design, syn...
[[abstract]]Nanotechnology can be defined as the science and engineering involved in the design, syn...
Cardiovascular diseases are the leading cause of mortality in the Western world. Among them, atheros...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries,...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries,...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries,...
Coronary artery disease (CAD) is one of the most common causes of death worldwide. In the last decad...
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality worldwide. However,...
Cardiovascular diseases (CVDs) represent the most important epidemic of our century, with more than ...
Coronary artery disease (CAD) is currently a leading cause of death worldwide. In the history of per...
Coronary artery disease (CAD) is one of the most common causes of death worldwide. In the last decad...
Tao Li,* Weitao Liang,* Xijun Xiao, Yongjun Qian Department of Cardiovascular Surgery, West China H...